South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1. 46 billion Swiss francs ($1. 8 billion) for Switzerland's PolyPeptide Group.
Source: [CNBC](https://www.cnbc.com/2026/07/20/samsung-biologics-polypeptide-group-deal-switzerland.html)